Clinical Trials Logo

Clinical Trial Summary

The objective of the study was to evaluate the safety and efficacy of OTX-DP (dexamethasone insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who had undergone cataract extraction with intraocular lens implantation


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02089113
Study type Interventional
Source Ocular Therapeutix, Inc.
Contact
Status Completed
Phase Phase 3
Start date April 2014
Completion date March 2015

See also
  Status Clinical Trial Phase
Completed NCT02736175 - OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery Phase 3
Completed NCT04324359 - Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects Phase 2
Recruiting NCT04592081 - Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL. Phase 4